Authors


Song Wang

Latest:

How to Address—and Overcome—Operational Challenges in Master Protocol Studies

Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.


Jana von Hehn, PhD

Latest:

Enhancing Care and Research: Digital Technology's Impact on Rett Syndrome Management

Wearables have great potential to continue advancing research in Rett syndrome as well as other rare disease areas.


Shiri Diskin, PhD

Latest:

Turning Challenges into Opportunities: Evaluation of Digital Health Products

Shiri Diskin, PhD, Head of Medical Writing at Bioforum, sits down with Daphna Laifenfeld, PhD, Chief Scientific Officer at Ibex Medical Analytics to discuss the challenges associated with developing a CER and how to effectively navigate them while creating opportunities that increase efficiencies.


Lindsey Klane

Latest:

Improving Clinical Trial Patient Diversity: Can Central Imaging Play a Role?

Centralized medical imaging providers must challenge their current processes to improve patient diversity.


Hannah Jones, PhD

Latest:

Accelerating the Progress of Kinase Inhibitors in Oncology

The potential of PBPK modeling in answering key questions around these drugs.




InformedDNA

Latest:

Accelerate Clinical Trial Success with Genomics Experts

Webinar Date/Time: Thu, Mar 2, 2023 1:00 PM EST


Medidata, a Dassault Systèmes company

Latest:

Improving Diversity in Clinical Trials

Employing a Multi-faceted Approach to Cultivate Inclusivity and Close Disparity.



Gynet Santiago

Latest:

Streamlining Clinical Trials with eSource: Insights from MSK

A use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.


Dipak Kalra

Latest:

Innovations in Data Capture Transforming Trial Delivery

Advances in technology open door for improved EHR to EDC transfer process.


Noël France

Latest:

Considerations to Reach Underrepresented Groups

Regulatory compliance, collaboration, and effective use of technology among ways CROs can overcome challenges.


Beth Harper

Latest:

Assessing Investigative Site Outlook and Operating Experience Post-Pandemic

Tufts CSDD survey finds fostering healthy relationships with site staff is key to a positive outlook.


Sikich

Latest:

3 Ways to Turn Client Experience into Your Competitive Advantage

*** Thursday, March 11, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET *** How can CROs continue to grow in today’s increasingly competitive market? Learn how you can turn client experience into your competitive advantage. *** On demand available after final airing until Mar. 11, 2022 ***


Neil Spooner

Latest:

Opportunities for Improving Clinical Decisions with Patient Centric Remote Blood Sampling Approaches

This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.


Biswamohan Routray

Latest:

Future of Clinical Trial Documentation Management: eTMF Integrated with Blockchain

eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.


Mike Hughes

Latest:

Prioritizing Patients: Strategies and eCOA Best Practices in Drug Development

A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.


Sheelagh Aird

Latest:

Central RBM Supports Reduced Cost, Higher Data Quality

Implementing centralized risk-based monitoring can help meet strict GCP requirements for study conduct, oversight, and recording.


Fenja Kruse

Latest:

What the Future of Study Review Processes Should Look Like

Insights from Bayer’s study review process showcases importance of incorporating feedback from a wider audience of stakeholders.


Anusha Shetty

Latest:

Four-Steps to Accelerate Study Start-up Cycles

Identifying KPIs, benchmarks, key data points, and an actionable plan are all keys to accelerating study start-up cycles.


Jaydev Thakkar, MBA

Latest:

How Today’s Digitally Driven Research Could Drive CAR T-cell Therapy Protocols of the Future

New protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.


Harold Strandquist

Latest:

Better Cardiac Safety Trials

Tips for reducing site queries and improving workflows.


Ben Thomas

Latest:

What Patients Expect from Clinical Trials in the COVID-19 Era

Key takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.


Liisa M. Eisenlohr

Latest:

Targeting Patient Population

Keys to ensuring your clinical trials better reflect your target population.


Julia Beck, PhD

Latest:

At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ Device

Laboratory services organization focuses on easing patient and site burden with improved collection device.


Melanie Owen

Latest:

How to Address—and Overcome—Operational Challenges in Master Protocol Studies

Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.


Catalyst

Latest:

Enhancing Clinical Trial Flexibility

As drug development costs continue to escalate, sponsors are incentivized to find less expensive approaches to develop their assets. FSP models provide increased operational and resourcing flexibility and different pricing plans in comparison to traditional full-service CRO offerings.


Lev Korolkov

Latest:

Evaluation of Different NLP Models for Parsing and Extraction of Clinical Data from Scientific Articles

Natural language processing models are able to automate the extraction of pertinent information from a vast array of scientific literature.


Dario Lirio

Latest:

The Impact of Automated Safety Document Distribution on Pharmacovigilance and Patient Safety

Automating process can reduce time and resources lost from using manual steps and allows stakeholders to maintain compliance.

© 2024 MJH Life Sciences

All rights reserved.